Elite Pharmaceuticals, Inc. (ELTP)
0.2891
-0.01
(-2.00%)
USD |
OTCM |
Aug 24, 16:00
Elite Pharmaceuticals 1 Year Total Returns (Daily) : -47.33% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -47.33% |
| August 21, 2026 | -46.85% |
| August 20, 2026 | -47.21% |
| August 19, 2026 | -46.85% |
| August 18, 2026 | -47.13% |
| August 17, 2026 | -43.23% |
| August 14, 2026 | -41.49% |
| August 13, 2026 | -32.36% |
| August 12, 2026 | -36.62% |
| August 11, 2026 | -36.66% |
| August 10, 2026 | -38.37% |
| August 07, 2026 | -36.11% |
| August 06, 2026 | -34.03% |
| August 05, 2026 | -32.85% |
| August 04, 2026 | -26.67% |
| August 03, 2026 | -23.48% |
| July 31, 2026 | -25.71% |
| July 30, 2026 | -29.14% |
| July 29, 2026 | -31.93% |
| July 28, 2026 | -31.57% |
| July 27, 2026 | -30.24% |
| July 24, 2026 | -28.50% |
| July 23, 2026 | -31.81% |
| July 22, 2026 | -32.18% |
| July 21, 2026 | -28.63% |
| Date | Value |
|---|---|
| July 20, 2026 | -31.19% |
| July 17, 2026 | -31.69% |
| July 16, 2026 | -24.72% |
| July 15, 2026 | -29.26% |
| July 14, 2026 | -30.74% |
| July 13, 2026 | -29.40% |
| July 10, 2026 | -29.00% |
| July 09, 2026 | -35.78% |
| July 08, 2026 | -37.03% |
| July 07, 2026 | -41.26% |
| July 06, 2026 | -39.89% |
| July 02, 2026 | -43.15% |
| July 01, 2026 | -46.40% |
| June 30, 2026 | -50.12% |
| June 29, 2026 | -44.45% |
| June 26, 2026 | -45.88% |
| June 25, 2026 | -49.61% |
| June 24, 2026 | -52.26% |
| June 23, 2026 | -51.73% |
| June 22, 2026 | -51.15% |
| June 18, 2026 | -46.27% |
| June 17, 2026 | -52.38% |
| June 16, 2026 | -50.15% |
| June 15, 2026 | -45.31% |
| June 12, 2026 | -50.67% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Nektar Therapeutics | 172.6% |
| Daré Bioscience, Inc. | -62.19% |
| Eton Pharmaceuticals, Inc. | 272.4% |
| ANI Pharmaceuticals, Inc. | -18.50% |
| Corcept Therapeutics, Inc. | 75.23% |